Welcome to LookChem.com Sign In|Join Free
  • or
2-Pyrimidinamine, 4-[(5S)-2-(4-fluorophenyl)-6,7-dihydro-5-[[(4-methoxyphenyl)methoxy]methyl]-5H-pyrrolo[1,2-a]imidazol-3-yl]-N-propyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

869287-23-0

Post Buying Request

869287-23-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

869287-23-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 869287-23-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,2,8 and 7 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 869287-23:
(8*8)+(7*6)+(6*9)+(5*2)+(4*8)+(3*7)+(2*2)+(1*3)=230
230 % 10 = 0
So 869287-23-0 is a valid CAS Registry Number.

869287-23-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[(5S)-2-(4-Fluorophenyl)-5-{[(4-methoxybenzyl)oxy]methyl}-6,7-d ihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-N-propyl-2-pyrimidinamine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:869287-23-0 SDS

869287-23-0Relevant academic research and scientific papers

The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold

Graczyk, Piotr P.,Khan, Afzal,Bhatia, Gurpreet S.,Palmer, Vanessa,Medland, Darren,Numata, Hirotoshi,Oinuma, Hitoshi,Catchick, Jacqueline,Dunne, Angela,Ellis, Moira,Smales, Caroline,Whitfield, Jonathan,Neame, Stephen J.,Shah, Bina,Wilton, Daniel,Morgan, Louise,Patel, Toshal,Chung, Raymond,Desmond, Howard,Staddon, James M.,Sato, Nobuaki,Inoue, Atsushi

, p. 4666 - 4670 (2007/10/03)

Imidazole-based structures of p38 inhibitors served as a starting point for the design of JNK3 inhibitors. Construction of a 6,7-dihydro-5H-pyrrolo[1,2-a] imidazole scaffold led to the synthesis of the (S)-enantiomers, which exhibited p38/JNK3 IC50 ratio of up to 10 and were up to 20 times more potent inhibitors of JNK3 than the relevant (R)-enantiomers. The JNK3 inhibitory potency correlated well with inhibition of c-Jun phosphorylation and neuroprotective properties of the compounds in low K+-induced cell death of rat cerebellar granule neurones.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 869287-23-0